Optiver Holding B.V. Makes New Investment in CVS Health Co. (NYSE:CVS)

Optiver Holding B.V. bought a new stake in shares of CVS Health Co. (NYSE:CVS) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,607 shares of the pharmacy operator’s stock, valued at approximately $117,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Quarry LP purchased a new stake in shares of CVS Health during the 4th quarter valued at approximately $97,000. Mission Creek Capital Partners Inc. lifted its stake in shares of CVS Health by 30.3% in the 4th quarter. Mission Creek Capital Partners Inc. now owns 9,995 shares of the pharmacy operator’s stock valued at $449,000 after acquiring an additional 2,324 shares during the last quarter. Aquatic Capital Management LLC lifted its stake in shares of CVS Health by 258.1% in the 4th quarter. Aquatic Capital Management LLC now owns 751,948 shares of the pharmacy operator’s stock valued at $33,755,000 after acquiring an additional 541,948 shares during the last quarter. Oxford Asset Management LLP raised its position in CVS Health by 110.4% during the 4th quarter. Oxford Asset Management LLP now owns 17,999 shares of the pharmacy operator’s stock valued at $808,000 after purchasing an additional 9,443 shares during the last quarter. Finally, Boothbay Fund Management LLC bought a new position in CVS Health during the 4th quarter valued at approximately $300,000. 80.66% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Michael F. Mahoney bought 30,000 shares of the business’s stock in a transaction dated Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares of the company’s stock, valued at approximately $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares in the company, valued at $556,941.90. This trade represents a 47.23 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.22% of the company’s stock.

CVS Health Price Performance

CVS stock opened at $64.91 on Tuesday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The business has a 50 day simple moving average of $66.45 and a 200-day simple moving average of $58.75. The firm has a market capitalization of $81.84 billion, a PE ratio of 17.74, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $71.45.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Equities research analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.10%. The ex-dividend date of this dividend is Tuesday, April 22nd. CVS Health’s payout ratio is currently 72.68%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Barclays increased their target price on CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. UBS Group cut their target price on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 11th. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. Wolfe Research upped their price target on shares of CVS Health from 67.00 to 70.00 and gave the company an “overweight” rating in a research report on Tuesday, February 11th. Finally, JPMorgan Chase & Co. increased their target price on shares of CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a report on Tuesday, February 18th. Four investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $71.83.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.